Company news
Sinovac Biotech, Ltd. news in 2022
Sinovac Biotech, Ltd.'s news releases, calls and decks from 2022, newest first.
SINOVAC Reports Unaudited First Half of 2022 Financial Results
December 28, 2022
SINOVAC Varicella Vaccine Prequalified by WHO
November 2, 2022
SINOVAC to Showcase Products at CPHI Frankfurt
October 27, 2022
SINOVAC Approved to Initiate Clinical Trial for Its Omicron Containing COVID-19 Vaccine in Chile
September 5, 2022
SINOVAC COVID-19 Vaccine Approved for Use in Children Above 6 months of Age in Hong Kong
August 2, 2022
SINOVAC Initiates Clinical Trial for Its Quadrivalent Influenza Vaccine in Chile
July 18, 2022
SINOVAC COVID-19 Vaccine Is Authorized for Emergency Use in Kids Aged 3-5 In Brazil
July 13, 2022
SINOVAC COVID-19 Vaccine Is Conditionally Registered In South Africa
June 24, 2022
SINOVAC Polio Vaccine Prequalified by WHO
June 7, 2022
SINOVAC Updates the Status Under Holding Foreign Companies Accountable Act
May 5, 2022
SINOVAC Reports Unaudited Second Half of 2021 Financial Results and Files 2021 Annual Report on Form 20-F
April 28, 2022